Video

Dr Jeff Patton Outlines How Community Oncology Is a Low-Cost, High-Quality Provider

Having the option of receiving care in their community instead of a large hospital located hours away is not only a benefit for many patients, but research is showing community oncology practices are a low-cost, high-quality provider of care, explained Jeff Patton, MD, executive chairman of Tennessee Oncology and CEO of OneOncology.

Having the option of receiving care in their community instead of a large hospital located hours away is not only a benefit for many patients, but research is showing community oncology practices are a low-cost, high-quality provider of care, explained Jeff Patton, MD, executive chairman of Tennessee Oncology and CEO of OneOncology.

How will hospital price transparency impact community oncologists?

So, I hope that the pricing transparency shines a bright light on what we already knew, which is to show the payers in the world that we are the low-cost, high-quality provider, and that hopefully, that will allow a steerage of patients our way and really drive our businesses and help us thrive.

Since the first paper was published, on January the 15th, I've done 4 talks. My talk [September 24] is about hospital transparency, largely talking about that community oncology is the high-quality, low-cost provider. Now we have data to prove it. And so, there was, just a couple weeks ago, an article published about the 340B hospitals and the transparency, and they're marking up those discounted prices as much as the other acute care hospitals.

So, I hope that transparency drives payers to have better conversations with us and hopefully stops the mass exodus of community oncology to hospitals and allows physicians that want to come back and practice in the community the opportunity to do so.

What's the role and benefit of a community oncologist versus a big medical center?

So, for me, the primary thing is that we're able to deliver care at a convenient place close to where patients live, instead of in a hospital campus where it's, you know, hard to park. In Tennessee, we go out to rural areas an hour outside of Nashville, and it's just mom and pop, and we're delivering care right there in the community where patients are in a very convenient location. That's one.

Two, as independent oncologists, we own our practice, so we get to make our own rules and we're very nimble, and so we can adjust to changes in both care and care patterns, and the regulatory environment. And so, the independence of owning your own practice and providing a more convenient location for patients, to me, it's a lovely combination.

Other than COVID-19, what is the biggest challenge facing community oncologists right now?

I think it's always, you know, worried about what the government's going to do. There are unintended consequences, just like 340B, I think has ballooned into something it shouldn't have. And it's pushed physicians toward hospitals, which is a more expensive site of service, which we now have proof of. So, I don't worry about the government doing things, you know, against us, I worry about them doing things that have unintended consequences. And so, there are a lot.

Now the cost of cancer care is exploding, and they want to do something—I just worry that they'll do something that's not right for community oncology. And I know that patients deserve the choice of either been cared for in their communities, where they live, or going to a large hospital in a large city. That should be their choice, but I think they should have that choice instead of, unfortunately, the wrong law could push the world such that we can't practice independently, which would be a shame.

Related Videos
Keith Ferdinand, MD, professor of medicine, Gerald S. Berenson chair in preventative cardiology, Tulane University School of Medicine
Screenshot of an interview with Shaun P. McKenzie, MD
Hans Lee, MD
Don M. Benson, MD, PhD, James Cancer Hospital
Picture of San Diego skyline with words ASH Annual Meeting 2024 and health icons overlaid on the bottom
Robin Glasco, MBA
Joshua K. Sabari, MD, NYU Langone Perlmutter Cancer Center
Kara Kelly, MD, chair of pediatrics, Roswell Park Oishei Children's Cancer and Blood Disorders Program
Hans Lee, MD
Screenshot of an interview with Amir Ali, PharmD, BCOP
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo